Second positive Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu in HER2-positive early breast cancer reinforces its potential to become a foundational treatment option in curative-intent setting
Prolia is a prescription medicine used to treat osteoporosis in women
The positive opinion is based on results from KOMET, the largest and only placebo-controlled, double-blind global Phase III trial in this patient population
Includes new $1.2 billion investment in manufacturing facilities, AI and advanced digital technologies, creating hundreds of highly skilled U.S. jobs
Encouraging early detection and breaking the silence around men’s health
The company is bringing precision therapies for gynaecological cancers
The Genexus platform enables Next-Generation Sequencing with significantly faster turnaround times
Addresses brain metastases harboring BRCA1/2 and/or HRR alterations—an area of high unmet need
Vevzuo is authorized for the prevention of skeletal related events in adults with advanced malignancies involving bone
Aumolertinib can be used in patients who have tested positive for a mutation in a gene called epidermal growth factor receptor
Subscribe To Our Newsletter & Stay Updated
